ZBH — Zimmer Biomet Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $24.54bn
- $29.90bn
- $7.39bn
- 95
- 36
- 77
- 79
Annual cashflow statement for Zimmer Biomet Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,132 | -9.2 | 446 | 291 | 1,025 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 154 | 706 | 352 | 443 | 97.3 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -168 | -430 | -134 | -311 | -396 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 1,586 | 1,205 | 1,499 | 1,285 | 1,582 |
| Capital Expenditures | -721 | -371 | -417 | -446 | -689 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -8.7 | -243 | -86.4 | -83 | -89.7 |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -729 | -614 | -504 | -529 | -779 |
| Financing Cash Flow Items | -25.3 | -100 | -173 | 466 | -26.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -780 | -422 | -1,306 | -844 | -764 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 75.1 | 184 | -324 | -103 | 40.1 |